Evaluation of beta-thalassemia in the fetus through cffDNA with multiple polymorphisms as a haplotype in the beta-globin gene
Tài liệu tham khảo
Lo, 1997, Presence of fetal DNA in maternal plasma and serum, Lancet, 350, 485, 10.1016/S0140-6736(97)02174-0
Greeley, 2015, Clinical applications of noninvasive prenatal testing, J Fetal Med, 2, 11, 10.1007/s40556-015-0035-1
Lun, 2008, Microfluidics digital PCR reveals a higher than expected fraction of fetal DNA in maternal plasma, Clin Chem, 54, 1664, 10.1373/clinchem.2008.111385
Barrett, 2011, Implementing prenatal diagnosis based on cell-free fetal DNA: accurate identification of factors affecting fetal DNA yield, PloS One, 6, e25202, 10.1371/journal.pone.0025202
Sun, 2019, Circulating cell-free DNA
Verhoef, 2016, Non-invasive prenatal diagnosis (NIPD) for single gene disorders: cost analysis of NIPD and invasive testing pathways, Prenat Diagn, 36, 636, 10.1002/pd.4832
Bustamante-Aragonés, 2012, Non-invasive prenatal diagnosis of single-gene disorders from maternal blood, Gene, 504, 144, 10.1016/j.gene.2012.04.045
Lench, 2013, The clinical implementation of non-invasive prenatal diagnosis for single-gene disorders: challenges and progress made, Prenat Diagn, 33, 555, 10.1002/pd.4124
Bustamante-Aragones, 2008, New strategy for the prenatal detection/exclusion of paternal cystic fibrosis mutations in maternal plasma, J Cyst Fibros, 7, 505, 10.1016/j.jcf.2008.05.006
Hill, 2015, Non-invasive prenatal diagnosis for cystic fibrosis: detection of paternal mutations, exploration of patient preferences and cost analysis, Prenat Diagn, 35, 950, 10.1002/pd.4585
Chitty, 2015, Non-invasive prenatal diagnosis of achondroplasia and thanatophoric dysplasia: next-generation sequencing allows for a safer, more accurate, and comprehensive approach, Prenat Diagn, 35, 656, 10.1002/pd.4583
Hui, 2017, Universal haplotype-based noninvasive prenatal testing for single gene diseases, Clin Chem, 63, 513, 10.1373/clinchem.2016.268375
Lo, 2010, Maternal plasma DNA sequencing reveals the genome-wide genetic and mutational profile of the fetus, Sci Transl Med, 2, 10.1126/scitranslmed.3001720
Lam, 2012, Noninvasive prenatal diagnosis of monogenic diseases by targeted massively parallel sequencing of maternal plasma: application to β-thalassemia, Clin Chem, 58, 1467, 10.1373/clinchem.2012.189589
New, 2014, Noninvasive prenatal diagnosis of congenital adrenal hyperplasia using cell-free fetal DNA in maternal plasma, J Clin Endocrinol Metab, 99, E1022, 10.1210/jc.2014-1118
Jenkins, 2018, Delivering an accredited non-invasive prenatal diagnosis service for monogenic disorders and recommendations for best practice, Prenat Diagn, 38, 44, 10.1002/pd.5197
Peng, 2017, Bioinformatics approaches for fetal DNA fraction estimation in noninvasive prenatal testing, Int J Molecular Sci, 18, 453, 10.3390/ijms18020453
Chiu, 2018, cfDNA screening and diagnosis of monogenic disorders – where are we heading?, Prenat Diagn, 38, 52, 10.1002/pd.5207
Wang, 1998, Large-scale identification, mapping, and genotyping of single-nucleotide polymorphisms in the human genome, Science, 280, 1077, 10.1126/science.280.5366.1077
Collins, 1997, Variations on a theme: cataloging human DNA sequence variation, Science, 278, 1580, 10.1126/science.278.5343.1580
Cotton, 2018, The human genome and neonatal care, 180
Hashemi-Soteh, 2017, Haplotypes inside the beta-globin gene: use as new biomarkers for beta-thalassemia prenatal diagnosis in north of Iran, J Biomed Sci, 24, 92, 10.1186/s12929-017-0396-y
Weatherall, 2010, Thalassemia as a global health problem: recent progress toward its control in the developing countries, Ann N Y Acad Sci, 1202, 17, 10.1111/j.1749-6632.2010.05546.x
Ostrowsky, 1985, Cost-benefit analysis of a thalassemia disease prevention program, Am J Public Health, 75, 732, 10.2105/AJPH.75.7.732
Abolghasemi, 2007, Thalassemia in Iran: epidemiology, prevention, and management, J Pediatr Hematol Oncol, 29, 233, 10.1097/MPH.0b013e3180437e02
Bazi, 2016, Spectrum of β-thalassemia mutations in Iran, an update, Iran J Pediatr Hematol Oncol, 6, 190
O’Leary, 2013, Prenatal screening for Down syndrome in Australia: costs and benefits of current and novel screening strategies, Aust N Z J Obstet Gynaecol, 53, 425, 10.1111/ajo.12136
Tabor, 2010, Update on procedure-related risks for prenatal diagnosis techniques, Fetal Diagn Ther, 27, 1, 10.1159/000271995
Li, 2009, Size fractionation of cell-free DNA in maternal plasma improves the detection of a paternally inherited β-thalassemia point mutation by MALDI-TOF mass spectrometry, Fetal Diagn Ther, 25, 246, 10.1159/000223442
Rafati, 2015, Microfluidic method for rapid turbidimetric detection of the DNA of Mycobacterium tuberculosis using loop-mediated isothermal amplification in capillary tubes, Microchimica Acta, 182, 523, 10.1007/s00604-014-1354-y
Akhavan-Niaki, 2012, Beta globin frameworks in Thalassemia major patients from North Iran, Iran J Pediatr, 22, 297
Chen, 2015, Non-invasive prenatal diagnosis using fetal DNA in maternal plasma: a preliminary study for identification of paternally-inherited alleles using single nucleotide polymorphisms, BMJ Open, 5, e007648, 10.1136/bmjopen-2015-007648
Huang, 2006, Improvement of methods for the isolation of cell-free fetal DNA from maternal plasma: comparison of a manual and an automated method, Ann N Y Acad Sci, 1075, 308, 10.1196/annals.1368.041
Huang, 2008, Isolation of cell-free DNA from maternal plasma using manual and automated systems, 203
Holmberg, 2013, Akonni TruTip® and Qiagen® methods for extraction of fetal circulating DNA-evaluation by real-time and digital PCR, PloS one, 8.8, e73068, 10.1371/journal.pone.0073068
Ramezanzadeh, 2016, Detection of paternally inherited fetal point mutations for β-thalassemia in maternal plasma using simple fetal DNA enrichment protocol with or without whole genome amplification: an accuracy assessment, J Mater Fetal Neonatal Med, 29, 2645
Parks, 2017, Non-invasive prenatal diagnosis of spinal muscular atrophy by relative haplotype dosage, Eur J Hum Genet, 25, 416, 10.1038/ejhg.2016.195
Parks, 2016, Non-invasive prenatal diagnosis of Duchenne and Becker muscular dystrophies by relative haplotype dosage, Prenat Diag, 36, 312, 10.1002/pd.4781
Vermeulen, 2017, Sensitive monogenic noninvasive prenatal diagnosis by targeted haplotyping, Am J Hum Genet, 101, 326, 10.1016/j.ajhg.2017.07.012
Ye, 2018, Haplotype-based noninvasive prenatal diagnosis of hyperphenylalaninemia through targeted sequencing of maternal plasma, Sci Rep, 8, 1
Bruno, 2011, Extending the scope of diagnostic chromosome analysis: detection of single gene defects using high-resolution SNP microarrays, Hum Mutat, 32, 1500, 10.1002/humu.21581
Pergament, 2014, Single-nucleotide polymorphism – based noninvasive prenatal screening in a high-risk and low-risk cohort, Obstet Gynecol, 124, 210, 10.1097/AOG.0000000000000363
Everett, 2015, Cell-free fetal DNA: the new tool in fetal medicine, Ultrasound Obstet Gynecol, 45, 499, 10.1002/uog.14746
Ding, 2004, MS analysis of single-nucleotide differences in circulating nucleic acids: application to noninvasive prenatal diagnosis, Proc Natl Acad Sci, 101, 10762, 10.1073/pnas.0403962101
Darabi, 2018, An enrichment method of cell-free fetal DNA from mothers in the 11th week of pregnancy; on the way of non-invasive prenatal diagnosis of beta-thalassemia as a single gene disorder, J Sci Islamic Repub Iran, 29, 305
Zafari, 2016, High-resolution melting analysis for noninvasive prenatal diagnosis of IVS-II-I (GA) fetal DNA in minor beta-thalassemia mothers, J Mater Fetal Neonatal Med, 29, 3323